B0RC50 AF NFT

L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifiqc3qjeuyfhcw4kqtzevr4lvwy2x2jrglg46iqucvah2pk4kumm/metadata.json
IPFS of structure file: 
bafybeidueeza5t5cejrmlgiujy4uyl7tejgux2beqosu3ndsbfj76ms5fu/AF-B0RC50-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x89fd14a6A8d52484666c2dF913a3eb8aa7B160C6
First NFT owner address (bech32): 
genesis13873ff4g65jggenv9hu38glt32nmzcxxusswv2
Current NFT ID #245212 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
245212
Accession (UniProt):
B0RC50
Name::
L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase
Experimental Method:
Predicted structure
Sequence source:
Clavibacter michiganensis subsp. sepedonicus (strain ATCC 33113 / DSM 20744 / JCM 9667 / LMG 2889 / C-1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0RC50 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0RC50|MSHC_CLAMS L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase OS=Clavibacter michiganensis subsp. sepedonicus (strain ATCC 33113 / DSM 20744 / JCM 9667 / LMG 2889 / C-1) OX=31964 GN=mshC PE=3 SV=1 MFDTSAGSVRPAECTGDGRVGLYVCGITPYDATHIGHASTYLAFDTLQRVWLDRGYDVAYVQNVTDVDDPLLERATATGVDWRDLAAEQVELFRTDMEALRILPPDSYVGVTEVVDEVASAVAELVRRGTAYPVATPDAVVAGAQDLYFDVARAGEDGPWALGDESGYDLDTMAALSAERGGDPERPGKRDPLDPLLWRAERAGEPAWDSVVGRGRPGWHIECAVIALRKLDRPVTVQGGGSDLIFPHHEMSAGHAAALTGEDFACVYAHSGMVAYQGEKMSKSLGNLVLVSRLRAAGVDPRAIRLALLAQHYRADWEWTDELLAESVARLAAWDAWAAAADASATAGADAGEPGELVQLVRERLSEDLDTPGAILLLDLRVATGVPATPVELAAVDALLGVRLGSPAA